Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Molecules ; 28(1)2022 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-36615495

RESUMO

The worldwide known and employed spice of Asian origin, turmeric, receives significant attention due to its numerous purported medicinal properties. Herein, we report an optimized synthesis of curcumin and symmetric curcuminoids of aromatic (bisdemethoxycurcumin) and heterocyclic type, with yields going from good to excellent using the cyclic difluoro-boronate derivative of acetylacetone prepared by reaction of 2,4-pentanedione with boron trifluoride in THF (ca. 95%). The subsequent cleavage of the BF2 group is of significant importance for achieving a high overall yield in this two-step procedure. Such cleavage occurs by treatment with hydrated alumina (Al2O3) or silica (SiO2) oxides, thus allowing the target heptanoids obtained in high yields as an amorphous powder to be filtered off directly from the reaction media. Furthermore, crystallization instead of chromatographic procedures provides a straightforward purification step. The ease and efficiency with which the present methodology can be applied to synthesizing the title compounds earns the terms "click" and "unclick" applied to describe particularly straightforward, efficient reactions. Furthermore, the methodology offers a simple, versatile, fast, and economical synthetic alternative for the obtention of curcumin (85% yield), bis-demethoxycurcumin (78% yield), and the symmetrical heterocyclic curcuminoids (80-92% yield), in pure form and excellent yields.


Assuntos
Curcumina , Curcumina/química , Diarileptanoides , Dióxido de Silício , Curcuma/química , Extratos Vegetais/química
2.
Coord Chem Rev ; 372: 117-140, 2018 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-32226092

RESUMO

In the last 30 years, since the discovery that vanadium is a cofactor found in certain enzymes of tunicates and possibly in mammals, different vanadium-based drugs have been developed targeting to treat different pathologies. So far, the in vitro studies of the insulin mimetic, antitumor and antiparasitic activity of certain compounds of vanadium have resulted in a great boom of its inorganic and bioinorganic chemistry. Chemical speciation studies of vanadium with amino acids under controlled conditions or, even in blood plasma, are essential for the understanding of the biotransformation of e.g. vanadium antidiabetic complexes at the physiological level, providing clues of their mechanism of action. The present article carries out a bibliographical research emphaticizing the chemical speciation of the vanadium with different amino acids and reviewing also some other important aspects such as its chemistry and therapeutical applications of several vanadium complexes.

3.
Rev. colomb. ciencias quim. farm ; 46(2): 220-234, May-Aug. 2017. tab, graf
Artigo em Inglês | LILACS | ID: biblio-900643

RESUMO

SUMMARY Density, ultrasonic velocity and viscosity of some vanillin Schiff bases derivatives have been studied in methanol and tetrahydrofuran (THF) at 308.15 K. From the experimental data, various acoustical parameters such as isentropic compressibility (κ s), Rao's molar sound function (R m ), Van der Waals constant (b), relaxation strength (r), intermolecular free length (L f ), apparent molar compressibility, etc. have been evaluated, which helps in understanding the molecular interactions occurring in these solutions.


RESUMEN En este trabajo se estudiaron la densidad, la velocidad ultrasónica y la viscosidad de soluciones de algunas bases de Schiff derivadas de la vainillina en metanol y tetrahidrofurano (THF) a 308,15 K. A partir de los datos experimentales, se evaluaron diversos parámetros acústicos, como la compresibilidad isentrópica (k s ), la función acústica molar de Rao (R m ), la constante de Van der Waals (b), la fuerza de relajación (r), la longitud intermolecular libre (L f ), la compresibilidad molar aparente, etc., todo lo cual ayuda a comprender las interacciones moleculares que ocurren en estas soluciones.

4.
J Nutr ; 147(9): 1677-1685, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28724658

RESUMO

Background: The effects of high-dose folic acid (FA) supplementation in healthy individuals on blood folate concentrations and immune response are unknown.Objective: The aim of the study was to evaluate the effects of daily consumption of a tablet containing 5 mg FA on serum folate; number and cytotoxicity of natural killer (NK) cells; mRNA expression of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR), interferon γ (IFNG), tumor necrosis factor α (TNFA), and interleukin 8 (IL8) genes; and concentrations of serum inflammatory markers.Methods: This prospective clinical trial was conducted in 30 healthy Brazilian adults (15 women), aged 27.7 y (95% CI: 26.4, 29.1 y), with a body mass index (in kg/m2) of 23.1 (95% CI: 22.0, 24.3). Blood was collected at baseline and after 45 and 90 d of the intervention. Serum folate concentrations were measured by microbiological assay and HPLC-tandem mass spectrometry [folate forms, including unmetabolized folic acid (UMFA)]. We used real-time polymerase chain reaction to assess mononuclear leukocyte mRNA expression and flow cytometry to measure the number and cytotoxicity of NK cells.Results: Serum folate concentrations increased by ∼5-fold after the intervention (P < 0.001), and UMFA concentrations increased by 11.9- and 5.9-fold at 45 and 90 d, respectively, when compared with baseline (P < 0.001). UMFA concentrations increased (>1.12 nmol/L) in 29 (96.6%) participants at day 45 and in 26 (86.7%) participants at day 90. We observed significant reductions in the number (P < 0.001) and cytotoxicity (P = 0.003) of NK cells after 45 and 90 d. Compared with baseline, DHFR mRNA expression was higher at 90 d (P = 0.006) and IL8 and TNFA mRNA expressions were higher at 45 and 90 d (P = 0.001 for both).Conclusion: This noncontrolled intervention showed that healthy adults responded to a high-dose FA supplement with increased UMFA concentrations, changes in cytokine mRNA expression, and reduced number and cytotoxicity of NK cells. This trial was registered at www.ensaiosclinicos.gov.br as RBR-2pr7zp.


Assuntos
Suplementos Nutricionais/efeitos adversos , Ácido Fólico/efeitos adversos , Mediadores da Inflamação/sangue , Interleucina-8/sangue , Células Matadoras Naturais , Fator de Necrose Tumoral alfa/sangue , Adulto , Brasil , Feminino , Ácido Fólico/administração & dosagem , Ácido Fólico/sangue , Humanos , Imunidade/efeitos dos fármacos , Masculino , Metilenotetra-Hidrofolato Redutase (NADPH2)/genética , Metilenotetra-Hidrofolato Redutase (NADPH2)/metabolismo , Estado Nutricional , Estudos Prospectivos , RNA Mensageiro/metabolismo , Reação em Cadeia da Polimerase em Tempo Real , Valores de Referência , Tetra-Hidrofolato Desidrogenase/genética , Tetra-Hidrofolato Desidrogenase/metabolismo , Fator de Necrose Tumoral alfa/genética , Complexo Vitamínico B/administração & dosagem , Complexo Vitamínico B/efeitos adversos , Complexo Vitamínico B/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA